The PROTEMBO Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 284 participants.

Also called NCT05873816

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 284 participants (enrolled count) (from the registry)
Sponsor
Protembis GmbH (from the registry)
Registry
  • NCT NCT05873816
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Germany, Poland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05873816. Randomized; double masking; primary purpose prevention. Start 2024-03-21 (actual); primary completion 2025-10-18 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The PROTEMBO Trial
Condition
Severe Aortic Valve Stenosis
Intervention (Device)
ProtEmbo - Cerebral Embolic Protection
Intervention (Device)
Sentinel - Cerebral Embolic Protection
Lead sponsor
Protembis GmbH (class: industry)

Record details

Record id
cardio:ct-nct05873816
Content hash
9d8c892f3208f92565b915a1467832dfedcc72e25d2c2eb21867166bfe49cac7